Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imagion Biosystems.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Sluggish day for the ASX as crude oil bleeds out 4.0pc
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
News
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
Health & Biotech
Imagion raises $3m to advance MagSense cancer diagnosis platform
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
News
ASX Small Caps Lunch Wrap: Who spent $150k on a piece of violent hip-hop history today?
News
ASX Small Caps Lunch Wrap: Who else should try to lose some risk appetite today?
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: The RBA’s interest rate lever pulling finally pays off, sending the ASX up 1.1%
News
ASX Small Caps and IPO Weekly Wrap: ASX falls 1.1% for the week, an ass-kicking we probably didn’t deserve
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Investors respond to the government’s Critical Minerals Strategy by selling everything in sight
News
